Nimish B Vakil

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. ncbi request reprint Epigastric pain in dyspepsia and reflux disease
    Nimish Vakil
    University of Wisconsin Medical School, Madison, Wisconsin, USA
    Rev Gastroenterol Disord 3:S16-21. 2003
  2. ncbi request reprint Seven-day therapy for Helicobacter pylori in the United States
    N Vakil
    University of Wisconsin Medical School, Milwaukee, WI 53233, USA
    Aliment Pharmacol Ther 20:99-107. 2004
  3. doi request reprint The initial diagnosis of GERD
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA Electronic address
    Best Pract Res Clin Gastroenterol 27:365-71. 2013
  4. doi request reprint Symptom Overlap Between Postprandial Distress and Epigastric Pain Syndromes of the Rome III Dyspepsia Classification
    Nimish Vakil
    University of Wisconsin, School of Medicine and Public Health, Madison, Wisconsin, USA
    Am J Gastroenterol 108:767-74. 2013
  5. doi request reprint Treatment for H. pylori infection: new challenges with antimicrobial resistance
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    J Clin Gastroenterol 47:383-8. 2013
  6. doi request reprint Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms
    Nimish B Vakil
    Department of Gastroenterology, Aurora Summit Hospital, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53066, USA
    Eur J Gastroenterol Hepatol 25:2-14. 2013
  7. doi request reprint Prescribing proton pump inhibitors: is it time to pause and rethink?
    Nimish Vakil
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI, USA
    Drugs 72:437-45. 2012
  8. ncbi request reprint Pretreatment endoscopy--pro & contra: is endoscopy needed before treatment in all patients with gastroesophageal reflux disease?
    N Vakil
    University of Wisconsin Medical School, Aurora Sinai Medical Center, 945 North 12th Street, Rm 4040, Milwaukee, WI 53233, USA
    Endoscopy 38:276-8. 2006
  9. ncbi request reprint Eradication therapy for Helicobacter pylori
    Nimish Vakil
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
    Gastroenterology 133:985-1001. 2007
  10. doi request reprint An international primary care survey of GERD terminology and guidelines
    Nimish Vakil
    Division of Gastroenterology, University of Wisconsin Medical School, Milwaukee, Wisc, USA
    Dig Dis 26:231-6. 2008

Collaborators

Detail Information

Publications66

  1. ncbi request reprint Epigastric pain in dyspepsia and reflux disease
    Nimish Vakil
    University of Wisconsin Medical School, Madison, Wisconsin, USA
    Rev Gastroenterol Disord 3:S16-21. 2003
    ..The large number of patients presenting with epigastric pain has led to the development of empirical strategies...
  2. ncbi request reprint Seven-day therapy for Helicobacter pylori in the United States
    N Vakil
    University of Wisconsin Medical School, Milwaukee, WI 53233, USA
    Aliment Pharmacol Ther 20:99-107. 2004
    ..The ideal duration of Helicobacter pylori treatment in the United States and whether eradication therapy is as successful in nonulcer dyspepsia as in peptic ulcer disease are controversial topics...
  3. doi request reprint The initial diagnosis of GERD
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA Electronic address
    Best Pract Res Clin Gastroenterol 27:365-71. 2013
    ..Using predominant symptoms to determine the path of treatment or the use of an empirical test of proton pump inhibitors has not been proven to be reliable and should be abandoned. ..
  4. doi request reprint Symptom Overlap Between Postprandial Distress and Epigastric Pain Syndromes of the Rome III Dyspepsia Classification
    Nimish Vakil
    University of Wisconsin, School of Medicine and Public Health, Madison, Wisconsin, USA
    Am J Gastroenterol 108:767-74. 2013
    ..The aim of this exploratory analysis was to evaluate the Rome III criteria and the validity of the PDS/EPS subgrouping in primary care patients with upper gastrointestinal symptoms...
  5. doi request reprint Treatment for H. pylori infection: new challenges with antimicrobial resistance
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    J Clin Gastroenterol 47:383-8. 2013
    ..With knowledge of local resistance patterns and with meticulous confirmation of eradication with retreatment, most H. pylori infections can be successfully eradicated...
  6. doi request reprint Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms
    Nimish B Vakil
    Department of Gastroenterology, Aurora Summit Hospital, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53066, USA
    Eur J Gastroenterol Hepatol 25:2-14. 2013
    ..Existing PRO instruments for GERD do not meet all the regulatory requirements for an outcome instrument in reflux trials and may need further validation...
  7. doi request reprint Prescribing proton pump inhibitors: is it time to pause and rethink?
    Nimish Vakil
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI, USA
    Drugs 72:437-45. 2012
    ..The absolute risk of all the complications attributed to PPIs is low and patients who need long-term PPI therapy need a clear discussion of the available data on the risk of therapy and also a discussion of the risk of continued reflux...
  8. ncbi request reprint Pretreatment endoscopy--pro & contra: is endoscopy needed before treatment in all patients with gastroesophageal reflux disease?
    N Vakil
    University of Wisconsin Medical School, Aurora Sinai Medical Center, 945 North 12th Street, Rm 4040, Milwaukee, WI 53233, USA
    Endoscopy 38:276-8. 2006
    ..In most developed countries, including western Europe and North America, middle-aged patients (over the age of 50) with gastroesophageal reflux disease would benefit more from colonoscopy than upper endoscopy...
  9. ncbi request reprint Eradication therapy for Helicobacter pylori
    Nimish Vakil
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
    Gastroenterology 133:985-1001. 2007
    ..In this article, we discuss the epidemiology and cellular mechanisms that result in antimicrobial resistance, the results of current eradication therapies, and new approaches to the management of Helicobacter pylori infection...
  10. doi request reprint An international primary care survey of GERD terminology and guidelines
    Nimish Vakil
    Division of Gastroenterology, University of Wisconsin Medical School, Milwaukee, Wisc, USA
    Dig Dis 26:231-6. 2008
    ..Terminology used to describe upper gastrointestinal disorders differs by country and language. However, the extent of variation in physician understanding of GERD and associated conditions and symptoms is not known...
  11. ncbi request reprint Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment
    Nimish B Vakil
    University of Wisconsin Medical School, Aurora Sinai Medical Center, Milwaukee 53201 0342, USA
    Clin Gastroenterol Hepatol 2:665-8. 2004
    ..Dysphagia is considered an alarm symptom, raising the question of stricture or malignancy. We sought to determine the prevalence and severity of dysphagia in patients with uncomplicated erosive esophagitis and its response to therapy...
  12. ncbi request reprint Review article: the role of surgery in gastro-oesophageal reflux disease
    N Vakil
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Aliment Pharmacol Ther 25:1365-72. 2007
    ..Rates for laparoscopic fundoplication are declining in the United States and there is no consensus on the indications for referral to surgery in gastro-oesophageal reflux disease...
  13. ncbi request reprint Toward a simplified strategy for managing dyspepsia
    Nimish Vakil
    University of Wisconsin Medical School, Madison, USA
    Postgrad Med 117:13-6. 2005
  14. ncbi request reprint Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
    N Vakil
    University of Wisconsin Medical School, Madison, WI, USA
    Aliment Pharmacol Ther 22:64-9. 2005
    ..Although a trial of acid suppression may have pragmatic value in clinical practice, the proton-pump inhibitor test is not an accurate test for the diagnosis of gastro-oesophageal reflux disease...
  15. ncbi request reprint Comprehension and awareness of symptoms in women with dyspepsia
    N Vakil
    University of Wisconsin Medical School, Madison, WI, USA
    Aliment Pharmacol Ther 22:1147-55. 2005
    ..Overlapping symptoms of gastro-oesophageal reflux disease and dyspepsia are a problem for physicians and patients...
  16. ncbi request reprint The frontiers of reflux disease
    Nimish Vakil
    University of Wisconsin Medical School, Madison, USA
    Dig Dis Sci 51:1887-95. 2006
    ....
  17. ncbi request reprint Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis
    Nimish Vakil
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53233, USA
    Gastroenterology 131:390-401; quiz 659-60. 2006
    ..The aim of this study was to determine the diagnostic accuracy of alarm features in predicting malignancy by performing a metaanalysis based on the published literature...
  18. ncbi request reprint The effect of over-the-counter ranitidine 75 mg on night-time heartburn in patients with erosive oesophagitis on daily proton pump inhibitor maintenance therapy
    N Vakil
    University of Wisconsin Medical School, Milwaukee, WI, USA
    Aliment Pharmacol Ther 23:649-53. 2006
    ..H2-receptor antagonists are widely used with proton pump inhibitors...
  19. ncbi request reprint Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia
    N Vakil
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Aliment Pharmacol Ther 24:55-63. 2006
    ..Aim To determine the incidence of symptoms of reflux disease and of erosive oesophagitis, and the relationship to changes in histological gastritis, in patients with non-ulcer dyspepsia over 12 months...
  20. ncbi request reprint Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease
    N Vakil
    University of Wisconsin Medical School, Madison, WI, USA
    Aliment Pharmacol Ther 19:1041-9. 2004
    ..One or more of these drug groups may represent the future medical therapy for gastro-oesophageal reflux disease, should they prove effective in the clinical setting. This review summarizes the state of the art with these agents...
  21. doi request reprint Body mass index and gastroesophageal reflux disease: implications of the obesity epidemic
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Dig Dis Sci 53:2291-2. 2008
  22. doi request reprint Disease definition, clinical manifestations, epidemiology and natural history of GERD
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, USA
    Best Pract Res Clin Gastroenterol 24:759-64. 2010
    ..Recent consensus efforts to define and classify the disease in both adults and children make it possible to obtain epidemiologic and natural history data using a universally acceptable definition and classification...
  23. ncbi request reprint Review article: test and treat or treat and test in reflux disease?
    N Vakil
    Division of Gastroenterology, University of Wisconsin Medical School, Milwaukee, Wisconsin 53233, USA
    Aliment Pharmacol Ther 17:57-9. 2003
    ..The role of endoscopic testing in the average patient is therefore shifting from a diagnostic modality to one that helps manage risk by identifying Barrett's oesophagus...
  24. doi request reprint Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study
    Nimish B Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53066, USA
    Am J Gastroenterol 106:1427-38. 2011
    ..It has been shown that arbaclofen placarbil (AP) inhibits reflux in gastroesophageal reflux disease (GERD) following single oral dosing. This study evaluated the efficacy and safety of AP over 4 weeks in subjects with symptomatic GERD...
  25. ncbi request reprint Nonulcer dyspepsia
    Nimish Vakil
    Division of Gastroenterology, Department of Medicine, University of Wisconsin Medical School, Aurora Sinai Medical Center, Milwaukee, WI 53233, USA
    Curr Gastroenterol Rep 4:455-8. 2002
    ..They are promising but need further study. Data are limited on 5-HT(3) antagonists and hypnotherapy. New treatment approaches are necessary for this common and often chronic condition...
  26. ncbi request reprint Review article: endoscopic treatments for gastro-oesophageal reflux disease
    N Vakil
    University of Wisconsin Medical School, Milwaukee, WI 53233, USA
    Aliment Pharmacol Ther 17:1427-34. 2003
    ..Future studies will need to use controls, validated outcome measures and pre-determined end-points and to provide comparative and long-term data...
  27. ncbi request reprint Are there geographical and regional differences in Helicobacter pylori eradication?
    Nimish Vakil
    University of Wisconsin Medical School, Aurora Sinai Medical Center, 945 N 12 Street, Room 4040, Milwaukee, WI 53233, USA
    Can J Gastroenterol 17:30B-32B. 2003
    ..Understanding the regional and geographical differences in H pylori eradication can help physicians select the optimal treatment regimen in different regions...
  28. ncbi request reprint Sequential therapy for Helicobacter pylori: time to consider making the switch?
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison
    JAMA 300:1346-7. 2008
  29. doi request reprint Expandable metal stents: principles and tissue responses
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison WI, USA
    Gastrointest Endosc Clin N Am 21:351-7, vii. 2011
    ..With biodegradable stents and removable stents, understanding tissue responses provides the basis for timing of removal and assessing treatment response...
  30. doi request reprint Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53233, USA
    Clin Gastroenterol Hepatol 7:756-61. 2009
    ..We investigated the prevalence of malignancies and other serious abnormalities in patients with dyspepsia and the cost of detecting these by endoscopy...
  31. ncbi request reprint Symptom response and healing of erosive esophagitis with proton-pump inhibitors in patients with Helicobacter pylori infection
    Nimish B Vakil
    Department of Gastroenterology, University of Wisconsin Medical School, Milwaukee, Wisconsin 53201 0342, USA
    Am J Gastroenterol 99:1437-41. 2004
    ..The aim of this article is to determine the severity of esophagitis and the response to treatment with proton-pump inhibitors in patients with and without evidence of Helicobacter pylori infection...
  32. ncbi request reprint A BALANCING VIEW: Endoscopy in dyspepsia: a tale of two cities
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Am J Gastroenterol 102:476-7. 2007
  33. ncbi request reprint Antimicrobial resistance and eradication strategies for Helicobacter pylori
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Rev Gastroenterol Disord 9:E78-83. 2009
    ..This article discusses the prevalence and mechanisms of resistance in H pylori and presents a strategy for eradication in patients harboring resistant strains...
  34. ncbi request reprint Gastroesophageal reflux disease and Helicobacter pylori infection
    Nimish Vakil
    Section of Gastroenterology, Department of Medicine, University of Wisconsin Medical School, Milwaukee, WI, USA
    Rev Gastroenterol Disord 3:1-7. 2003
    ..This article reviews each of the issues in the debate separately and concludes that there is little evidence to suggest a major effect of H. pylori eradication on the outcome of gastroesophageal reflux disease...
  35. doi request reprint Acid inhibition and infections outside the gastrointestinal tract
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
    Am J Gastroenterol 104:S17-20. 2009
    ....
  36. doi request reprint Proton pump inhibitors for dyspepsia
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, Wisc, USA
    Dig Dis 26:215-7. 2008
    ..Cost-effectiveness studies suggest that in young patients acid suppression alone is more cost-effective than either endoscopy or testing and treatment for H. pylori in areas with a low prevalence of H. pylori...
  37. ncbi request reprint Helicobacter pylori treatment: is sequential or quadruple therapy the answer?
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
    Rev Gastroenterol Disord 8:77-82. 2008
    ..Evidence shows that both quadruple therapy and sequential therapy are superior to triple therapy in patients with resistant strains of H. pylori. Studies that compare sequential and quadruple therapy are necessary and are awaited...
  38. ncbi request reprint Long-term strategies: a medico-economic perspective
    Nimish Vakil
    University of Wisconsin Medical School, Aurora Sinai Medical Center, Milwaukee 53233, USA
    Eur J Gastroenterol Hepatol 16:853-6. 2004
    ..The long-term management of the disease requires consideration of treatment efficacy and cost and must meet the needs of patients, physicians and third-party payers...
  39. ncbi request reprint Treatment of gastroesophageal reflux disease: defining endpoints that are important to patients
    Nimish Vakil
    University of Wisconsin Medical School and Marquette University College of Health Sciences, Milwaukee, Wisconsin, USA
    Rev Gastroenterol Disord 4:S3-7. 2004
    ....
  40. ncbi request reprint How to test for Helicobacter pylori in 2005
    Nimish Vakil
    University of Wisconsin Medical School, Milwaukee, WI, USA
    Cleve Clin J Med 72:S8-13; discussion S14-21. 2005
  41. ncbi request reprint Primary and secondary treatment for Helicobacter pylori in the United States
    Nimish Vakil
    University of Wisconsin Medical School and Marquette University College of Health Sciences, Milwaukee, Wisconsin, USA
    Rev Gastroenterol Disord 5:67-72. 2005
    ..This article discusses the issues involved in H. pylori eradication, the mechanism of antibiotic delivery to the mucus layer of the stomach, and primary and secondary treatment strategies for H. pylori in the United States...
  42. ncbi request reprint An overview of the success and failure of surgical therapy: standards against which the outcome of endoscopic therapy is measured
    Nimish Vakil
    University of Wisconsin Medical School, Aurora Sinai Medical Center, 945 North 12th Street, Room 4040, Milwaukee, WI 53233, USA
    Gastrointest Endosc Clin N Am 13:69-73, viii. 2003
    ..This article summarizes the needed studies and the standards against which these procedures should be measured...
  43. ncbi request reprint Clinical effectiveness of laparoscopic fundoplication in a U.S. community
    Nimish Vakil
    Department of Medicine, Division of Gastroenterology, University of Wisconsin Medical School, Aurora Sinai Medical Center, Milwaukee, 53233, USA
    Am J Med 114:1-5. 2003
    ..The aim of our study was to determine the outcome of laparoscopic fundoplication for reflux disease in a cohort of patients who underwent this procedure in routine clinical practice...
  44. ncbi request reprint Novel methods of using proton-pump inhibitors
    Nimish Vakil
    University of Wisconsin Medical School, Aurora Sinai Medical Center, 945 North 12th Street, Room 4040, Milwaukee, WI 53233, USA
    Gastroenterol Clin North Am 31:S85-8. 2002
    ..There are few data on nocturnal symptoms, and some studies suggest that tachyphylaxis may develop with H2RA therapy. More data are required on the clinical effectiveness of combination therapy administered long-term...
  45. ncbi request reprint Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy
    Cristino Canga
    University of Wisconsin Medical School, Milwaukee 53233, USA
    Am J Gastroenterol 97:600-3. 2002
    ....
  46. ncbi request reprint Low-dose aspirin: protection from the panacea
    Nalini Guda
    University of Wisconsin Medical School, Milwaukee, USA
    Am J Gastroenterol 97:3202-3. 2002
  47. ncbi request reprint Increasing compliance with long-term therapy: avoiding complications and adverse events
    Nimish Vakil
    University of Wisconsin Medical School, Madison, Wisconsin, USA
    Rev Gastroenterol Disord 5:S12-7. 2005
    ..Similarly, long-term therapy administered continuously reduces complications such as stricture and may decrease the development of dysplasia in Barrett's esophagus...
  48. doi request reprint Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin and Marquette University College of Health Sciences, Milwaukee, Wisconsin 53233, USA
    Am J Gastroenterol 103:1906-19. 2008
    ..Therapies for dysmotility-like functional dyspepsia (FD) are limited. We studied tegaserod, a selective serotonin type 4 receptor agonist, in patients with FD...
  49. ncbi request reprint Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors
    James M Scheiman
    Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    Am J Gastroenterol 101:701-10. 2006
    ..Such studies are particularly relevant, given that concerns regarding adverse cardiovascular outcomes among COX-2 inhibitor users may prompt re-evaluation of their use...
  50. ncbi request reprint Non-invasive tests for the diagnosis of H. pylori infection
    Nimish Vakil
    University of Wisconsin Medical School, Milwaukee, Wisconsin, USA
    Rev Gastroenterol Disord 4:1-6. 2004
    ..The choice of an appropriate test depends on the pre-test probability of infection, the characteristics of the test being used, and the cost-effectiveness of the test. This article reviews available non-invasive tests...
  51. ncbi request reprint The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
    Rev Gastroenterol Disord 6:221-6. 2006
    ..Alternate therapies include use of non-NSAID analgesics; low-dose NSAIDs; and concurrent administration of cytoprotective agents with NSAIDs, acid inhibitors, proton pump inhibitors, and COX-2 agents...
  52. ncbi request reprint Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage?
    Nalini M Guda
    University of Wisconsin Medical School, Milwaukee, Wisconsin, USA
    Am J Gastroenterol 99:1233-7. 2004
    ..Since 2001, one intravenous proton pump inhibitor (pantoprazole) has been available in the United States. A drug shortage bulletin was issued for this agent in 2003...
  53. ncbi request reprint New pharmacological agents for the treatment of gastroesophageal reflux disease
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
    Rev Gastroenterol Disord 8:117-22. 2008
    ..These include agents that reduce TLESRs, serotonergic agents/ prokinetics, long-acting PPIs, mucosal protectants, and antigastrin agents. One or more of these agents may be the future of GERD therapy...
  54. ncbi request reprint Peptic ulcer bleeding: clips, heat, and outcome
    A Quadri
    University of Wisconsin Medical School, Milwaukee, USA
    Am J Gastroenterol 97:200-1. 2002
  55. ncbi request reprint Unrecognized GERD symptoms are associated with excessive daytime sleepiness in patients undergoing sleep studies
    Nalini Guda
    Department of Gastroenterology, Aurora Sinai Medical Center, Milwaukee, Wisconsin 53233, USA
    Dig Dis Sci 52:2873-6. 2007
    ..Patients with GERD had significantly greater sleepiness. Further studies of the impact of GERD treatment in this population are necessary...
  56. ncbi request reprint Advances in gastrointestinal pharmacotherapy
    David C Metz
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Gastroenterol Hepatol 3:1167-79. 2005
    ..Nevertheless, the success of new biologics such as anti-TNFalpha agents augurs well for effective future therapies...
  57. ncbi request reprint Usage of supplemental alternative medicine by community-based patients with gastroesophageal reflux disease (GERD)
    Craig W Hayden
    Southem Arizona VA Health Care System and University of Arizona Health Sciences Center, Department of Medicine, Tucson 85723, USA
    Dig Dis Sci 47:1-8. 2002
    ..Being female and having acid regurgitation daily were positively associated with alternative medicine usage for GERD...
  58. ncbi request reprint Proton pump inhibitors and the time trends for esophageal dilation
    Nalini M Guda
    University of Wisconsin Medical School, Aurora Sinai Medical Center, Milwaukee, Wisconsin 53233, USA
    Am J Gastroenterol 99:797-800. 2004
    ..To determine the time trends for upper endoscopy and stricture dilation before and after the availability of proton pump inhibitors...
  59. ncbi request reprint The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus
    Nimish Vakil
    University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53233, USA
    Am J Gastroenterol 101:1900-20; quiz 1943. 2006
    ..The aim of this initiative was to develop a consensus definition and classification that would be useful for patients, physicians, and regulatory agencies...
  60. ncbi request reprint Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis
    Donald O Castell
    Department of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston 29425, USA
    Am J Gastroenterol 97:575-83. 2002
    ..This study compared esomeprazole with lansoprazole for the healing of erosive esophagitis and resolution of heartburn...
  61. ncbi request reprint Dyspepsia management in primary care: a decision analysis of competing strategies
    Brennan M R Spiegel
    Department of Medicine and Health Services Research, Cedars Sinai Medical Center, Los Angeles, California, USA
    Gastroenterology 122:1270-85. 2002
  62. ncbi request reprint Comparison of inter- and intraobserver consistency for grading of esophagitis by expert and trainee endoscopists
    John E Pandolfino
    Northwestern University Medical School, Chicago, Illinois 60611, USA
    Gastrointest Endosc 56:639-43. 2002
    ..This study evaluated intra- and interobserver variability in the endoscopic scoring of esophagitis by using two grading schemes, the Los Angeles and Hetzel-Dent scales...
  63. ncbi request reprint Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies
    Brennan M R Spiegel
    Department of Digestive Diseases, University of California at Los Angeles School of Medicine, Los Angeles, California, USA
    Am J Gastroenterol 98:86-97. 2003
    ..Our objective was to evaluate the cost-effectiveness of competing strategies for the posthemostasis management of patients with high risk ulcer stigmata...
  64. ncbi request reprint A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States
    Pelham M Barton
    Health Economics Facility, University of Birmingham, UK
    Med Decis Making 28:44-55. 2008
    ..The objective of this study was to explore uncertainty in controversial areas of the 2005 American Gastroenterology Association position statement on the management of dyspepsia...
  65. ncbi request reprint American gastroenterological association technical review on the evaluation of dyspepsia
    Nicholas J Talley
    Division of Gastroenterology and Hepatology and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota
    Gastroenterology 129:1756-80. 2005
  66. doi request reprint Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?
    Alexander C Ford
    Gastroenterology Division, McMaster University Medical Centre, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada
    JAMA 300:1793-805. 2008
    ..These individuals are frequently diagnosed with irritable bowel syndrome (IBS) based on their symptoms; however, some may require additional testing or referral to specialists before this diagnosis is made...